Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

A new flu vaccine using messenger RNA technology is available at some King Soopers pharmacies in Colorado, offering adults 50 ...

Moderna’s dramatic ascent this year has been fueled by optimism that its personalized cancer vaccine could reshape oncology and redefine the company beyond its pandemic-era success. That promise may ...

Add Yahoo as a preferred source to see more of our stories on Google. A Moderna logo is displayed on a building in Cambridge, Massachusetts, on Sept. 5, 2024. The Food and Drug Administration has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Moderna (MRNA) stock surged 14% after reports of a new NIH cancer research initiative and encouraging trial data with Merck.

Moderna (NASDAQ:MRNA) shares climb on cancer vaccine optimism, index inclusion and a Health Canada flu vaccine review. See what's driving it.

Healthcare is drawing fresh buying as money moves away from the market’s popular technology trade, and one messenger RNA ...

Few large biotech stocks have rewarded patience like Moderna (NASDAQ:MRNA | MRNA Price Prediction), and the size of that run now raises a hard question about what comes next. Moderna stock is up 545% ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the ...

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, ...